Publications – KalVista Pharmaceuticals | KalVista Pharmaceuticals

Patients & Caregivers
- About HAE
Healthcare Professionals
Clinical Trials
Presentations & Publications
Investors & News

About
Science
Pipeline
Careers
- Careers
- Job Openings
Contact

Bringing new developments to Light

Presentations & Publications

We are committed to rigorous science and innovative drug development, and we are excited to share our ongoing progress.

Explore Our
Virtual Medical Booth

Reset all ×
HAE attack journey data ×
Publication ×
2023 ×

Apply Reset

Topic

Sebetralstat (KVD900) in HAE clinical program (0)
HAE attack journey data (1)
HAE burden of treatment data (0)
Oral Factor XIIa inhibitor (0)
Kallikrein-Kinin System science (0)

Forum

Medical Meeting (10)
Publication (1)

Year

2023 (1)
2022 (0)
2024 (1)

Apply Reset

Showing 1 out of 1

Hereditary Angioedema With Normal C1 Inhibitor: US Survey of Prevalence and Provider Practice Patterns

Riedl MA, Danese M, Danese S, Ulloa J, Maetzel A, Audhya PK

J Allergy Clin Immunol Pract

About

Management team

Board of Directors

Science

Pipeline

Oral Factor XIIa Inhibitor

Careers

Contact

KalVista Terms of Use Privacy Policy

© 2024 KalVista Pharmaceuticals. All Rights Reserved.